Anti-herpesvirus polychemotherapy.
D000818:Animals; D003847:Deoxyglucose / Q000627:therapeutic use; D003857:Deoxyuridine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006801:Humans; D007635:Keratitis, Dendritic / Q000188:drug therapy*; D009705:Nucleosides / Q000627:therapeutic use*; D010746:Phosphonoacetic Acid / Q000627:therapeutic use; D011817:Rabbits; D018139:Simplexvirus / Q000187:drug effects; D014271:Trifluridine / Q000627:therapeutic use; D014740:Vidarabine / Q000627:therapeutic use
D009705:Nucleosides; D003847:Deoxyglucose; D014740:Vidarabine; D010746:Phosphonoacetic Acid; D014271:Trifluridine; D003857:Deoxyuridine